Robinson, Michael R.,Burke, James A.,Liu, Hui,Orilla, Werhner C.,Spada, Lon T.,Whitcup, Scott,Ghebremeskel, Alazar N.,Hughes, Patrick M.,Xu, Kun,Do, Marianne M.
申请号：
AU2018211329
公开号：
AU2018211329A1
申请日:
2018.08.03
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018211329A120180823.pdf#####I: mdt Interwo n NRPortbl DCC MDT I 1455033_.docx-22 09/2016 INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING OCULAR CONDITIONS Abstract Biocompatible, bioerodible sustained release implants and microspheres for intracameral or anterior vitreal placement include an anti-hypertensive agent and a biodegradable polymer effective to treat an ocular hypertensive condition (such as glaucoma) by relapsing therapeutic amount of the anti-hypertensive agent over a period of time between 10 days and 1 year.
